Paradigm Biocapital Advisors LP - 30 Jun 2025 SCHEDULE 13G/A Report for Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Janux Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
JANX
Shares outstanding
59,597,102 shares
Disclosed Ownership
2,920,258 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:31:25 UTC
Date of event
30 Jun 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 4.9% 2,920,258 2,920,258 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 4.9% 2,920,258 2,920,258 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 4.9% 2,920,258 2,920,258 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.4% 2,593,376 2,593,376 0 /s/ David K. Kim David K. Kim / Authorized Signatory